🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and assertions of next-day British shipping. Vendors promote the substance there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Some professionals stated the popularity for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Service Reaction and Content Elimination

According to the social media company, the service has removed problematic material and banned associated hashtags and query recommendations. The organization said it was committed to keeping the platform safe and investing in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of users, populated with photos of weight loss, glowing testimonials and detailed instructions for mixing or administering at residence.

After moments of joining one community, a seller shared contact information, where the majority of purchases occur. The seller sent an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about body mass, health issues or past usage.

Product Details and Costs

Inside these communities, posts show black plastic packages with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service said it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has previously seen patients harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to potentially serious health risks”.